PerkinElmer to buy Horizon Discovery in £284m deal
2nd Nov 2020 12:20
(Sharecast News) - Horizon Discovery shares surged on Monday after it agreed to be bought by PerkinElmer in a deal that values the cell engineering company at around £284m.
Read moreHorizon Discovery restarts efforts towards US offering
22nd Jul 2020 16:05
(Sharecast News) - Horizon Discovery Group updated the market on its plans for a public offering in the United States on Wednesday, confirming it was restarting its efforts to go ahead with one.
Read moreHorizon Discovery shores up capital with placing
17th Apr 2020 13:39
(Sharecast News) - Cell engineering company Horizon Discovery Group announced its intention to conduct a non-preemptive placing of up to 6,764,365 new ordinary shares on Friday, representing about 4.5% of its current issued share capital.
Read moreHorizon Discovery revenues grow following strong FY performance
4th Feb 2020 08:34
(Sharecast News) - Gene editing and modulation firm Horizon Discovery expects full-year revenues to show some year-on-year improvement after a strong performance from its research reagents and screening business units.
Read moreHorizon Discovery inks strategic partnership with Mammoth Biosciences
13th Dec 2019 08:27
(Sharecast News) - Life sciences firm Horizon Discovery has signed a strategic collaboration deal with Mammoth Biosciences that will see the two companies develop new clustered regularly interspaced short palindromic repeat (CRISPR) tools.
Read moreHorizon Discovery offloads In Vivo business to Envigo
8th Nov 2019 12:09
(Sharecast News) - Gene editing and gene modulation technology company Horizon Discovery Group announced an agreement to divest its In Vivo business unit to Envigo RMS on Friday, for a nominal consideration satisfied in cash.
Read moreFriday broker round-up
8th Nov 2019 11:54
(Sharecast News) - Tate & Lyle: Kepler Cheuvreux upgrades to hold with a target price of 720p.
Read moreHorizon Discovery turns EBITDA positive following Dharmacon acquisition
29th Jan 2019 08:31
(Sharecast News) - Gene editing and modulation business Horizon Discovery expects to have turned EBITDA positive in its recently wrapped up trading year as a result of significantly improved revenues.
Read moreHorizon Discovery agrees gene editing partnership with Rutgers
28th Jan 2019 12:49
(Sharecast News) - Horizon Discovery Group has entered into an exclusive strategic partnership with Rutgers, The State University of New Jersey, to develop and commercialise a novel gene editing technology, known as base editing.
Read moreHorizon Discovery looks to grow revenue as it teams up with pharmaceutical
14th Feb 2017 09:15
(ShareCast News) - Gene editing technology company Horizon Discovery has teamed up with a global pharmaceutical to support its drug discovery developments as it aims to increase revenue in 2017. The AIM-listed company penned a master service agreement with the pharmaceuticals adding to its original
Read moreHorizon Discovery's full year revenue rises as volumes increase
24th Jan 2017 10:44
(ShareCast News) - Horizon Discovery Group, a maker of gene editing technologies, saw revenue increased last year, driven by better-than-expected sales volumes. For the 2016 calendar year, revenue climbed 19% to £24m compared to the previous year, with gross margin increasing to the mid-50% range, f
Read moreHorizon Disc gains Chinese partnerships to develop tumor diagnostic kit
16th Nov 2016 10:01
(ShareCast News) - Horizon Discovery, a developer of gene editing technologies, has entered into partnerships with three Chinese diagnostic kit developers to treat tumours. The company will provide HDx Reference Standards for next generation sequencing assay development, clinical trials, and for inc
Read moreHorizon Discovery inks subscription-based licensing deal
19th Oct 2016 13:59
(ShareCast News) - Horizon Discovery has inked a subscription-based licensing deal for its biomanufacturing cell lines. The deal, the first of its type for the company and with an unnamed commercial partner, is worth a minimum of £500,000. "We look forward to making further announcements in this are
Read moreHorizon Discovery signs development agreement with Ventanta
1st Sep 2016 11:13
(ShareCast News) - Gene editing technologies company Horizon Discovery Group announced on Thursday that it has entered into a co-development and commercialisation agreement with Ventana Medical Systems, a member of the Roche Group. The AIM-traded firm said the agreement covers the development, manuf
Read moreRevenues grow, losses widen at Horizon Discovery
26th Apr 2016 15:43
(ShareCast News) - Gene-editing technology company Horizon Discovery Group saw revenues grow sizably in the 2015 calendar year, it reported on Tuesday, though losses also widened. The AIM-traded firm reported a 69% increase in total group revenue to £20.2m, with product revenues growing 124% to £7.8
Read more